Optimization to detect TP53 mutations in circulating cell-free tumor DNA from patients with serous epithelial ovarian cancer
Yu Ran Park, Yong-Man Kim, Shin Wha Lee, Ha Young Lee, Gun Eui Lee, Jong-Eun Lee, Young-Tak Kim
Obstet Gynecol Sci. 2018;61(3):328-336.   Published online 2018 May 8     DOI: https://doi.org/10.5468/ogs.2018.61.3.328
Citations to this article as recorded by Crossref logo
Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
Du-Bois Asante, Leslie Calapre, Melanie Ziman, Tarek M. Meniawy, Elin S. Gray
Cancer Letters.2020; 468: 59.     CrossRef
TP53 Mutations in Serum Circulating Cell-Free Tumor DNA As Longitudinal Biomarker for High-Grade Serous Ovarian Cancer
Silvia R. Vitale, Floris H. Groenendijk, Ronald van Marion, Corine M. Beaufort, Jean C. Helmijr, Hendrikus Jan Dubbink, Winand N. M. Dinjens, Patricia C. Ewing-Graham, Ramon Smolders, Helena C. van Doorn, Ingrid A. Boere, Els M. J. J. Berns, Jozien Hellem
Biomolecules.2020; 10(3): 415.     CrossRef
Prediction of the treatment response in ovarian cancer: a ctDNA approach
Mina Sharbatoghli, Somayeh Vafaei, Hamidreza Aboulkheyr Es, Mohsen Asadi-Lari, Mehdi Totonchi, Zahra Madjd
Journal of Ovarian Research.2020;[Epub]     CrossRef
The P72R Polymorphism in R248Q/W p53 Mutants Modifies the Mutant Effect on Epithelial to Mesenchymal Transition Phenotype and Cell Invasion via CXCL1 Expression
Cristabelle De Souza, Jill A. Madden, Dennis Minn, Vigneshwari Easwar Kumar, Dennis J. Montoya, Roshni Nambiar, Zheng Zhu, Wen-Wu Xiao, Neeki Tahmassebi, Harikumara Kathi, Nina Nelson, Anthony N. Karnezis, Jeremy Chien
International Journal of Molecular Sciences.2020; 21(21): 8025.     CrossRef
Evaluation of circulating tumor DNA as a biomarker for gynecological tumors
Kang-Sheng Liu, Hua Tong, Tai-Ping Li, Ya-Jun Chen
Chinese Medical Journal.2020; 133(21): 2613.     CrossRef
Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer
Jiyoon Bu, Tae Hee Lee, Woo-jin Jeong, Michael J. Poellmann, Kara Mudd, Hyuk Soo Eun, Elizabeth W. Liu, Seungpyo Hong, Sung Hee Hyun, Jeffrey Chalmers
PLOS ONE.2020; 15(12): e0242145.     CrossRef
Non-invasive Technology Advances in Cancer—A Review of the Advances in the Liquid Biopsy for Endometrial and Ovarian Cancers
Mark R. Openshaw, Terri P. McVeigh
Frontiers in Digital Health.2020;[Epub]     CrossRef
Diagnostic Value of Concentration of Circulating Cell-Free DNA in Breast Cancer: A Meta-Analysis
Dandan Yu, Yan Tong, Xinnian Guo, Lingfang Feng, Zhaoqiang Jiang, Shibo Ying, Junlin Jia, Yuan Fang, Min Yu, Hailing Xia, Li Shi, Jianlin Lou
Frontiers in Oncology.2019;[Epub]     CrossRef
Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review
Klara Cervena, Pavel Vodicka, Veronika Vymetalkova
Mutation Research/Reviews in Mutation Research.2019; 781: 100.     CrossRef
Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes
Lydia Giannopoulou, Martha Zavridou, Sabine Kasimir-Bauer, Evi S. Lianidou
Translational Research.2019; 205: 77.     CrossRef
Circulating tumor cells and cell-free nucleic acids in patients with gynecological malignancies
Ben Davidson
Virchows Archiv.2018; 473(4): 395.     CrossRef
Circulating tumor DNA – Current state of play and future perspectives
Gabriele De Rubis, Sabna Rajeev Krishnan, Mary Bebawy
Pharmacological Research.2018; 136: 35.     CrossRef